| US4052509A (en) | 1972-12-18 | 1977-10-04 | Affiliated Medical Research, Inc. | Method for reducing serum uric acid levels |
| ES421598A1 (en) | 1972-12-18 | 1977-01-01 | Affiliated Med Res | Pharmaceutical composition |
| US4042699A (en) | 1972-12-18 | 1977-08-16 | Affiliated Medical Research, Inc. | Method for reducing serum glucose levels |
| US3839346A (en) | 1972-12-18 | 1974-10-01 | Affiliated Med Res | N-substituted pyridone and general method for preparing pyridones |
| CA1049411A (en) | 1972-12-18 | 1979-02-27 | Affiliated Medical Research | N-substituted pyridone and general method for preparing pyridones |
| US4105782A (en) | 1975-03-07 | 1978-08-08 | Yu Ruey J | Treatment of acne and dandruff |
| JPS51128433A (en) | 1975-04-30 | 1976-11-09 | Ajinomoto Co Inc | A herbicide |
| SE430609B (en) | 1976-12-21 | 1983-11-28 | Sca Development Ab | SET TO CELLULOUS DERIVATIVES MAKE ABSORBING MATERIAL |
| US4376118A (en) | 1980-10-06 | 1983-03-08 | Miles Laboratories, Inc. | Stable nonaqueous solution of tetracycline salt |
| US5310562A (en) | 1989-11-22 | 1994-05-10 | Margolin Solomon B | Composition and method for reparation and prevention of fibrotic lesions |
| US5009895A (en) | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
| ATE224712T1 (en) | 1993-05-07 | 2002-10-15 | Solomon B Margolin | COMPOSITIONS AND METHODS FOR REPAIRING AND PREVENTING FIBROTIC INJURIES |
| CZ293747B6 (en) | 1995-12-21 | 2004-07-14 | Pfizer Inc. | Aqueous pharmaceutical solution suitable for injection into a host and use thereof |
| US5958420A (en) | 1997-03-13 | 1999-09-28 | Nortrade Medical, Inc. | Treatment of burns, cuts, and abrasions of the skin |
| US6365131B1 (en) | 1997-10-31 | 2002-04-02 | J. B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic |
| CA2322994A1 (en) | 1998-03-17 | 1999-09-23 | Solomon B. Margolin | Topical antiseptic compositions and methods |
| GB9810949D0 (en) | 1998-05-22 | 1998-07-22 | Hewlett Healthcare Limited | Formulation |
| WO2000016775A1 (en) | 1998-09-18 | 2000-03-30 | Mepha Ag | Topical formulation of alkyl-, phenyl-pyridone |
| US20020028784A1 (en) | 2000-03-10 | 2002-03-07 | Nest Gary Van | Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences |
| IN191090B (en) | 2000-08-29 | 2003-09-20 | Ranbanx Lab Ltd | |
| DE60234812D1 (en) | 2001-01-29 | 2010-02-04 | Shionogi & Co | DRUG PROTEIN CONTAINING 5-METHYL-1-PHENYL-2- (1H) -PYRIDONE AS ACTIVE INGREDIENT |
| AU2002348534A1 (en) | 2001-10-09 | 2003-04-22 | The Children's Hospital Of Philadelphia | Materials and methods for preventing or reducing scar formation |
| CH696420A5 (en) | 2002-09-13 | 2007-06-15 | Mepha Ag | New stable formulations of alkyl, phenyl-pyridones for topical use. |
| WO2004073713A1 (en) | 2003-02-21 | 2004-09-02 | Shionogi & Co., Ltd. | Pirfenidone gel preparation |
| WO2004078194A1 (en) | 2003-02-28 | 2004-09-16 | Intermune, Inc. | Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
| WO2004078207A1 (en) | 2003-02-28 | 2004-09-16 | Intermune, Inc. | Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
| WO2004089283A2 (en) | 2003-04-04 | 2004-10-21 | Intermune, Inc. | Compositions and methods for treating viral infections |
| EP1638625A4 (en)* | 2003-05-23 | 2009-08-19 | David M Ott | Organosulphur prodrugs for the prevention and treatment of infectious diseases and pathologenic immune system response |
| US20080025986A1 (en) | 2003-06-06 | 2008-01-31 | Ozes Osman N | Methods of Treating Tnf-Mediated Disorders |
| US7491794B2 (en) | 2003-10-14 | 2009-02-17 | Intermune, Inc. | Macrocyclic compounds as inhibitors of viral replication |
| CA2540858C (en) | 2003-10-14 | 2009-12-08 | Intermune, Inc. | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| US7407973B2 (en) | 2003-10-24 | 2008-08-05 | Intermune, Inc. | Use of pirfenidone in therapeutic regimens |
| WO2005067454A2 (en) | 2003-12-23 | 2005-07-28 | Valeant Pharmaceuticals North America | Combination therapy for treating hepatitis c virus infection |
| CN100542532C (en) | 2004-05-24 | 2009-09-23 | 上海睿星基因技术有限公司 | The purposes of pirfenidone in the medicine of preparation treatment hepatic injury necrosis and acute lung injury |
| US20060051339A1 (en) | 2004-09-08 | 2006-03-09 | Sivak Hannah N | Composition for treatment of oily skin and acne prevention and methods of making and using same |
| US20060115503A1 (en) | 2004-11-30 | 2006-06-01 | Goyal Muna C | Composition, system and method for treatment of skin |
| ES2600460T3 (en) | 2005-05-10 | 2017-02-09 | Intermune, Inc. | Pyridone-2-one derivatives as modulators of the stress-activated protein kinase system |
| EP1924594A2 (en) | 2005-07-25 | 2008-05-28 | Intermune, Inc. | Novel macrocyclic inhibitors of hepatitis c virus replication |
| NZ591443A (en) | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
| CA2630752A1 (en) | 2005-11-23 | 2007-05-31 | Intermune, Inc. | Method of modulating stress-activated protein kinase system |
| WO2007068086A1 (en) | 2005-12-05 | 2007-06-21 | Bioartificial Gel Technologies Inc. | Emulsion-containing medical articles |
| CN101088557A (en) | 2006-06-12 | 2007-12-19 | 天津市扶素生物技术有限公司 | Medicine composition for preventing and treating HIV infection and its application |
| US20090047246A1 (en) | 2007-02-12 | 2009-02-19 | Intermune, Inc. | Novel inhibitors of hepatitis c virus replication |
| JP2010520194A (en) | 2007-03-02 | 2010-06-10 | ミロン、タリア | Mercaptopurine derivatives as anticancer agents |
| US20080287508A1 (en) | 2007-05-18 | 2008-11-20 | Intermune, Inc. | Altering pharmacokinetics of pirfenidone therapy |
| EP2170828B1 (en) | 2007-06-20 | 2012-11-21 | Auspex Pharmaceuticals, Inc. | Substituted n-aryl pyridinones as fibrotic inhibitors |
| MX2007009796A (en) | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel containing pirfenidone. |
| US20090137354A1 (en) | 2007-11-27 | 2009-05-28 | Shimano Inc. | Bicycle rear derailleur |
| EP2245061A2 (en) | 2007-12-11 | 2010-11-03 | Coda Therapeutics, Inc. | Impaired wound healing compositions and treatments |
| US20100256031A1 (en) | 2008-10-10 | 2010-10-07 | Jeffrey Wu | Shine control cleanser |
| US7635707B1 (en) | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
| AR075584A1 (en) | 2009-02-27 | 2011-04-20 | Intermune Inc | THERAPEUTIC COMPOSITIONS THAT INCLUDE beta-D-2'-DESOXI-2'-FLUORO-2'-C-METHYLYCTIDINE AND A CARDIEX ISOINDOL ACID DERIVATIVE AND ITS USES. COMPOUND. |
| CN101972236A (en) | 2010-10-13 | 2011-02-16 | 北京诚创康韵医药科技有限公司 | Sustained release preparation containing pirfenidone |
| CN101972225A (en) | 2010-10-13 | 2011-02-16 | 北京诚创康韵医药科技有限公司 | Pirfenidone-contained gel composition |
| WO2012106382A1 (en) | 2011-01-31 | 2012-08-09 | Genoa Pharmaceuticals, Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| WO2012112566A1 (en) | 2011-02-15 | 2012-08-23 | Allergan, Inc. | Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea |
| CN102670600A (en) | 2011-03-12 | 2012-09-19 | 赵海静 | Medicinal product for inhibiting scar and promoting wound healing, and preparation method and application of medicinal product |
| CN102670632A (en) | 2011-03-12 | 2012-09-19 | 赵海静 | Medical application of pirfenidone in inhibition of skin scar formation |
| US9241921B2 (en) | 2011-05-02 | 2016-01-26 | Pankaj Modi | Photosensitizer composition for treating skin disorders |
| MX2011007675A (en) | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Process for manufacturing a pharmaceutical composition in a sustained-release tablet form containing pirfenidone and the application thereof in the regression of chronic renal failure, breast capsular contracture and liver fibrosis in humans. |
| CN102488660A (en) | 2011-12-15 | 2012-06-13 | 西安天一秦昆制药有限责任公司 | Sustained-release pellet containing pirfeudone |
| MX346763B (en) | 2012-03-28 | 2017-03-31 | Cell Therapy And Tech S A De C V | Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne. |
| WO2013181691A1 (en) | 2012-06-04 | 2013-12-12 | The Macfarlane Burnet Institute For Medical Research And Public Health Ltd | A method of treatment and compositions useful therefor, screening and prognostic agents and uses therefor |
| TW201402133A (en) | 2012-06-12 | 2014-01-16 | Hoffmann La Roche | Combination therapeutic composition |
| MX356551B (en) | 2012-08-23 | 2018-06-04 | Grupo Medifarma S A De C V Star | Antiseptic, antiseborrheic, exfoliating composition for getting rid of or preventing acne. |
| CA2819967C (en) | 2012-08-31 | 2016-03-22 | Intermune, Inc. | Use of pirfenidone concomitantly with ciprofloxacin |
| AR092742A1 (en) | 2012-10-02 | 2015-04-29 | Intermune Inc | ANTIFIBROTIC PYRIDINONES |
| US10953021B2 (en) | 2013-03-15 | 2021-03-23 | Lupin Limited | Topical compositions of flunisolide and methods of treatment |
| US9156896B2 (en) | 2013-03-15 | 2015-10-13 | Coda Therapeutics, Inc. | Wound healing compositions and treatments |
| MX352342B (en) | 2013-07-12 | 2017-11-22 | Moleculas Naturales S A De C V Star | Process for the manufacture of improved benzethonium chloride-diallyl disulphide oxide modified complex, the obtained complex and uses thereof. |
| CN103550242B (en) | 2013-11-22 | 2015-07-15 | 四川国康药业有限公司 | Pharmaceutical composition for treating hepatic fibrosis and preparation method thereof |
| GB201508419D0 (en) | 2015-05-15 | 2015-07-01 | Cambridge Entpr Ltd | Detection of T cell exhaustion or lack of T cell costimulation and uses thereof |
| US20190000847A1 (en) | 2015-12-16 | 2019-01-03 | Daiichi Sankyo Company Limited | Therapeutic agent for a wound |
| JOP20170113B1 (en) | 2016-05-09 | 2023-03-28 | Bayer Pharma AG | 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine 3(2H)-substituted compounds and 2,5,6,7-tetrahydro-3H-pyrrolo[ 2,1-c][1,2,4]triazole-3-one and its uses |
| MX364040B (en) | 2016-11-11 | 2019-04-11 | Cell Therapy And Tech S A De C V | Pharmaceutical use of an extended-release composition containing pirfenidone for the treatment and reversal of human steatohepatitis (nafld/nash). |
| TWI770157B (en) | 2017-04-10 | 2022-07-11 | 德商拜耳廠股份有限公司 | Substituted n-arylethyl-2-aminoquinoline-4-carboxamides and use thereof |
| MX366086B (en) | 2017-08-15 | 2019-06-27 | Cell Therapy And Tech S A De C V | A semi-solid topical composition containing an antimicrobial agent and pirfenidone for the treatment of chronic skin damage. |
| MX368750B (en) | 2018-08-31 | 2019-10-15 | Cell Therapy And Tech S A De C V | Oil based semisolid pharmaceutical compositions containing pirfenidone for application in tissue repair. |